S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
NASDAQ:GLPG

Galapagos - GLPG Price Target & Analyst Ratings

$43.40
-0.27 (-0.62%)
(As of 02/2/2023 12:00 AM ET)
Add
Compare
Today's Range
$43.05
$44.07
50-Day Range
$37.44
$48.00
52-Week Range
$37.24
$72.11
Volume
111,414 shs
Average Volume
105,719 shs
Market Capitalization
$2.86 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$52.46

Galapagos Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 7 Analyst Ratings

Consensus Analyst Price Target

$52.40
20.74% Upside
High Prediction$57.00
Average Prediction$52.40
Low Prediction$47.20
TypeCurrent
2/3/22 to 2/3/23
1 Month Ago
1/4/22 to 1/4/23
3 Months Ago
11/5/21 to 11/5/22
1 Year Ago
2/3/21 to 2/3/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
4 Buy rating(s)
Hold
7 Hold rating(s)
6 Hold rating(s)
5 Hold rating(s)
7 Hold rating(s)
Sell
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$52.40$55.00$59.00$70.36
Predicted Upside20.74% Upside26.52% Upside16.41% Upside9.72% Upside
Get Galapagos Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GLPG and its competitors with MarketBeat's FREE daily newsletter.

GLPG Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

GLPG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Galapagos Stock vs. The Competition

TypeGalapagosMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.65
2.46
Consensus RatingHoldBuyHold
Predicted Upside20.74% Upside1,297.30% Upside7.33% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/23/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Hold$49.00 ➝ $47.20+3.01%
12/5/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral€65.00 ➝ €50.00
11/11/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target€50.00 ➝ €40.00
11/7/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSector Perform$55.00 ➝ $53.00+27.74%
11/7/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$63.00 ➝ $57.00+39.47%
11/7/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
10/14/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight€60.00 ➝ €50.00
5/12/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral€52.00 ➝ €70.00
1/28/2022Bryan, Garnier & Co
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Buy
1/27/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy
2/23/2021Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral$93.00 ➝ $94.00+9.70%
2/10/2021Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
12/17/2020Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy
10/21/2020The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Sell
9/25/2020Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Derek Archila
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
8/24/2020HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Debjit Chattopadhyay
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$270.00 ➝ $123.00-10.32%
8/19/2020Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
E. Merle
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral$192.00 ➝ $134.00-28.75%
5/21/2020Nomura
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$290.00+40.31%
2/26/2020Nomura Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$209.00 ➝ $290.00+21.81%
(Data available from 2/3/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












GLPG Price Target - Frequently Asked Questions

What is Galapagos's consensus rating and price target?

According to the issued ratings of 7 analysts in the last year, the consensus rating for Galapagos stock is Hold based on the current 7 hold ratings for GLPG. The average twelve-month price prediction for Galapagos is $52.40 with a high price target of $57.00 and a low price target of $47.20. Learn more on GLPG's analyst rating history.

Do Wall Street analysts like Galapagos more than its competitors?

Analysts like Galapagos less than other Medical companies. The consensus rating for Galapagos is Hold while the average consensus rating for medical companies is Buy. Learn more on how GLPG compares to other companies.

Is Galapagos being upgraded or downgraded by Wall Street analysts?

Over the previous 90 days, Galapagos's stock had 1 upgrade and 1 downgrade by analysts.

Does Galapagos's stock price have much upside?

According to analysts, Galapagos's stock has a predicted upside of 19.11% based on their 12-month price targets.

What analysts cover Galapagos?

Stock Ratings Reports and Tools

This page (NASDAQ:GLPG) was last updated on 2/3/2023 by MarketBeat.com Staff